Placental Assessment in Diabetic Mothers

Diabetes Clinical Trial

Official title:

Placental Assessment in Early and Late Pregnancy in Diabetic Women

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04149548
• Other study ID #: Diabetes mellitus
• Status: Recruiting
• Start date: November 5, 2019
• Est. completion date: December 1, 2020

Study information

• Verified date: February 2020
• Source: Aljazeera Hospital
• Contact: Mahmoud Alalfy, PhD
• Phone: 01002611058
• Email: mahmoudalalfy[@]ymail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Diabetes mellitus is one of the major heath problems

Description:

Maternal and fetal effects are edpected to be more than in diabetic mothers

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: December 1, 2020
• Est. primary completion date: November 6, 2020
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 20 Years to 42 Years

Eligibility

Inclusion Criteria:

• in control group A non diabetic pregnant women

Exclusion Criteria:

• Diabetic pregnant women

And the reverse in group B

Related Conditions & MeSH terms

• Diabetes

Intervention

Diagnostic Test:
• ultrasound
Obstetric ultrasound to pregnant women

Locations

Country	Name	City	State
Egypt	Algazeerah	Giza
Egypt	Algazeerah and Kasralainy hospital	Giza

Sponsors (1)

Lead Sponsor	Collaborator
Aljazeera Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The number of diabetic fetuses who will have undesirable effects	Number of fetuses with macrosomia and other diabetes effects	within 6 months